dc.contributor.author |
Mamouzelos, NJ |
en |
dc.contributor.author |
Proikakis, CS |
en |
dc.contributor.author |
Tarantili, PA |
en |
dc.contributor.author |
Andreopoulos, AG |
en |
dc.date.accessioned |
2014-03-01T01:18:17Z |
|
dc.date.available |
2014-03-01T01:18:17Z |
|
dc.date.issued |
2002 |
en |
dc.identifier.issn |
0885-3282 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/14921 |
|
dc.subject |
Biodegradable systems |
en |
dc.subject |
Controlled release |
en |
dc.subject |
Diclofenac |
en |
dc.subject |
DL-poly(lactic acid) |
en |
dc.subject |
Propranolol |
en |
dc.subject.classification |
Engineering, Biomedical |
en |
dc.subject.classification |
Materials Science, Biomaterials |
en |
dc.subject.other |
Biodegradation |
en |
dc.subject.other |
Biomaterials |
en |
dc.subject.other |
Biomedical engineering |
en |
dc.subject.other |
Molecular weight |
en |
dc.subject.other |
Organic polymers |
en |
dc.subject.other |
Polymerization |
en |
dc.subject.other |
Ultraviolet spectroscopy |
en |
dc.subject.other |
Biodegradable systems |
en |
dc.subject.other |
Controlled release |
en |
dc.subject.other |
Diclofenac |
en |
dc.subject.other |
Polylactic acid |
en |
dc.subject.other |
Propanolol |
en |
dc.subject.other |
Controlled drug delivery |
en |
dc.subject.other |
biomaterial |
en |
dc.subject.other |
diclofenac |
en |
dc.subject.other |
drug carrier |
en |
dc.subject.other |
lactic acid |
en |
dc.subject.other |
polylactic acid |
en |
dc.subject.other |
polymer |
en |
dc.subject.other |
propranolol |
en |
dc.subject.other |
article |
en |
dc.subject.other |
chemistry |
en |
dc.subject.other |
delayed release formulation |
en |
dc.subject.other |
differential scanning calorimetry |
en |
dc.subject.other |
infrared spectroscopy |
en |
dc.subject.other |
molecular weight |
en |
dc.subject.other |
pH |
en |
dc.subject.other |
viscosity |
en |
dc.subject.other |
Biocompatible Materials |
en |
dc.subject.other |
Calorimetry, Differential Scanning |
en |
dc.subject.other |
Delayed-Action Preparations |
en |
dc.subject.other |
Diclofenac |
en |
dc.subject.other |
Drug Carriers |
en |
dc.subject.other |
Hydrogen-Ion Concentration |
en |
dc.subject.other |
Lactic Acid |
en |
dc.subject.other |
Molecular Weight |
en |
dc.subject.other |
Polymers |
en |
dc.subject.other |
Propranolol |
en |
dc.subject.other |
Spectroscopy, Fourier Transform Infrared |
en |
dc.subject.other |
Viscosity |
en |
dc.title |
Release of propranolol and diclofenac from low Mw DL-poly(lactic acid) |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1177/0885328202016003174 |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1177/0885328202016003174 |
en |
heal.language |
English |
en |
heal.publicationDate |
2002 |
en |
heal.abstract |
The controlled release of two drugs, i.e. the sodium salt of diclofenac and propranolol was studied, by using low molecular weight D,L-Poly(lactic acid) as a matrix. Tablets of the above polymer containing those drugs were immersed into buffers with various pH values and delivery was recorded as a function of time, via UV-spectroscopy. The results showed that the polymer is appropriate for such biomedical applications, as generally, it ensures complete drug delivery within 45-60 days, which is acceptable for most cases. On the other hand, the release rate depends on many parameters including the interactions among drug, matrix and the surrounding liquid, which adds complexity to the process and requires careful investigation for proper design of a controlled release system. |
en |
heal.publisher |
SAGE PUBLICATIONS LTD |
en |
heal.journalName |
Journal of Biomaterials Applications |
en |
dc.identifier.doi |
10.1177/0885328202016003174 |
en |
dc.identifier.isi |
ISI:000174587100001 |
en |
dc.identifier.volume |
16 |
en |
dc.identifier.issue |
3 |
en |
dc.identifier.spage |
177 |
en |
dc.identifier.epage |
190 |
en |